Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04985721
Status:
RECRUITING
Last Update Posted:
2023-03-15
First Post:
2021-06-28
Brief Title:
A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects
Sponsor:
Organization:
Peter MacCallum Cancer Centre Australia